Pinnacle Associates’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$958K Buy
11,556
+1,530
+15% +$127K 0.01% 515
2025
Q1
$813K Sell
10,026
-350
-3% -$28.4K 0.01% 520
2024
Q4
$934K Buy
10,376
+3,385
+48% +$305K 0.01% 497
2024
Q3
$624K Sell
6,991
-3,355
-32% -$300K 0.01% 535
2024
Q2
$959K Buy
10,346
+1,760
+20% +$163K 0.02% 478
2024
Q1
$815K Buy
8,586
+1,595
+23% +$151K 0.01% 511
2023
Q4
$624K Sell
6,991
-770
-10% -$68.8K 0.01% 544
2023
Q3
$567K Buy
7,761
+2,010
+35% +$147K 0.01% 544
2023
Q2
$478K Hold
5,751
0.01% 578
2023
Q1
$438K Sell
5,751
-100
-2% -$7.62K 0.01% 549
2022
Q4
$486K Sell
5,851
-975
-14% -$80.9K 0.01% 508
2022
Q3
$541K Sell
6,826
-2,120
-24% -$168K 0.01% 487
2022
Q2
$664K Sell
8,946
-12,760
-59% -$947K 0.01% 481
2022
Q1
$1.95M Buy
21,706
+4,272
+25% +$384K 0.03% 349
2021
Q4
$1.95M Buy
17,434
+4,408
+34% +$494K 0.03% 352
2021
Q3
$1.64M Buy
13,026
+268
+2% +$33.7K 0.03% 371
2021
Q2
$1.73M Hold
12,758
0.03% 356
2021
Q1
$1.73M Sell
12,758
-15
-0.1% -$2.04K 0.03% 347
2020
Q4
$1.8M Sell
12,773
-35
-0.3% -$4.93K 0.04% 320
2020
Q3
$1.43M Sell
12,808
-145
-1% -$16.2K 0.03% 321
2020
Q2
$1.45M Buy
12,953
+3,082
+31% +$345K 0.04% 317
2020
Q1
$764K Sell
9,871
-1,184
-11% -$91.6K 0.02% 379
2019
Q4
$1.05M Buy
11,055
+1,636
+17% +$156K 0.02% 398
2019
Q3
$718K Buy
9,419
+1,102
+13% +$84K 0.02% 469
2019
Q2
$729K Buy
8,317
+657
+9% +$57.6K 0.02% 469
2019
Q1
$694K Buy
7,660
+3,585
+88% +$325K 0.02% 478
2018
Q4
$292K Sell
4,075
-4,924
-55% -$353K 0.01% 582
2018
Q3
$863K Buy
+8,999
New +$863K 0.02% 442